Transactions

Peterson Law represents Revive Therapeutics Ltd. as it closes $3,000,000 Public Offering of units

On December 18, 2014, Revive Therapeutics Ltd. (“Revive”) closed a public offering of 4,996,500 units (“Units”) at a price of $0.60 per Unit for gross proceeds of $2,997,900. Each Unit was comprised of one common share and one warrant entitling the holder thereof to purchase one additional common share for $0.85 for a period of two years from the date of issuance, subject to acceleration under certain circumstances.

Revive’s public offering was led by Beacon Securities Limited (“Beacon”) as the sole agent and bookrunner. Beacon was paid a cash commission and 349,755 compensation options, each such option entitling the holder to purchase one Unit for $0.60 for a period of two years from the date of issuance.

Back

Recent Transactions

31 December 2021

Peterson McVicar Acts for Bitfarms in $100 Million Credit Facility

Learn More

08 December 2021

Peterson McVicar Acts for Red Cloud in Upsize of Fission 3.0 Brokered Private Placement to up to C$7.5 Million

Learn More

11 November 2021

Peterson McVicar acts for Bitfarms as it Acquires 24 Megawatts of Hydro Power in the U.S. and Enters into Memorandum of Understanding to Expand Up to 99 MW

Learn More

09 November 2021

Peterson McVicar Acts for HIVE Blockchain in $110,020,000 Bought Deal Private Placement Financing

Learn More